Switzerland

In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed... 2008-06-24

The Swiss biotech sector attracted record levels of investment and healthy market growth during 2007, according Swiss Biotech's 2008 annual report. However, while company revenues... 2008-06-20

Switzerland-based drugmaker Nycomed is planning to sell part of its oncology pipeline to German firm 4SC in order to focus on developing drugs in its current areas of speciality.... 2008-06-06

Swiss pharmaceutical giant Novartis is to acquire US antibiotic developer Protez Pharmaceuticals in a deal worth up to US$400mn. Protez will become an independently-run subsidiary... 2008-06-05

Germany's main regulatory body, the Federal Institute for Drugs and Medical Devices (BfArM), has controversially approved a generic form of global blockbuster Plavix (clopidogrel).... 2008-05-30

Swiss drugmaker Novartis has obtained EU approval for its multiple sclerosis (MS) treatment Extavia (interferon beta-1b), which will result in a head-to-head battle with Bayer's identical... 2008-05-29

Swiss pharmaceutical giant Roche has recorded positive Q108 results for its Romanian operation, based in Bucharest. Sales were up by 25.7% year-on-year (y-o-y) to RON110.3mn (US$47.6mn)... 2008-05-21

Swiss pharmaceutical giant Novartis is set to acquire an US$11bn stake in the ophthalmic group Alcon from Nestlé. Novartis has announced that it will acquire 25% of Alcon for US$143.18... 2008-04-08

BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound... 2008-03-25

BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound... 2008-03-25